200 related articles for article (PubMed ID: 9595771)
21. Aflatoxins as risk factors for hepatocellular carcinoma in humans.
Wogan GN
Cancer Res; 1992 Apr; 52(7 Suppl):2114s-2118s. PubMed ID: 1311989
[TBL] [Abstract][Full Text] [Related]
22. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
23. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
24. Aflatoxin levels and prevalence of TP53 aflatoxin-mutations in hepatocellular carcinomas in Mexico.
Lino-Silva LS; Lajous M; Brochier M; Santiago-Ruiz L; Melchor-Ruan J; Xie Y; Wang M; Wu D; Higson H; Jones K; Romero-Martínez M; Villalpando S; Mohar A; Smith JW; Alvarez CS; McGlynn KA; Dean M; Groopman J
Salud Publica Mex; 2022 Feb; 64(1):35-40. PubMed ID: 35438902
[TBL] [Abstract][Full Text] [Related]
25. DNA polymerase ζ limits chromosomal damage and promotes cell survival following aflatoxin exposure.
Lin YC; Owen N; Minko IG; Lange SS; Tomida J; Li L; Stone MP; Wood RD; McCullough AK; Lloyd RS
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13774-13779. PubMed ID: 27849610
[TBL] [Abstract][Full Text] [Related]
26. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action.
Moore MM; Schoeny RS; Becker RA; White K; Pottenger LH
Crit Rev Toxicol; 2018 Apr; 48(4):312-337. PubMed ID: 29431554
[TBL] [Abstract][Full Text] [Related]
27. Absence of mutations in the p53 tumor suppressor gene in woodchuck hepatocellular carcinomas associated with hepadnavirus infection and intake of aflatoxin B1.
Rivkina M; Cote PJ; Robinson WS; Tennant BC; Marion PL
Carcinogenesis; 1996 Dec; 17(12):2689-94. PubMed ID: 9006107
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of emerging biomarkers of renal damage and exposure to aflatoxin-B
Díaz de León-Martínez L; Díaz-Barriga F; Barbier O; Ortíz DLG; Ortega-Romero M; Pérez-Vázquez F; Flores-Ramírez R
Environ Sci Pollut Res Int; 2019 Apr; 26(12):12205-12216. PubMed ID: 30835068
[TBL] [Abstract][Full Text] [Related]
29. Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).
Gross-Steinmeyer K; Eaton DL
Toxicology; 2012 Sep; 299(2-3):69-79. PubMed ID: 22640941
[TBL] [Abstract][Full Text] [Related]
30. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
31. AFB1 hepatocarcinogenesis is via lipid peroxidation that inhibits DNA repair, sensitizes mutation susceptibility and induces aldehyde-DNA adducts at p53 mutational hotspot codon 249.
Weng MW; Lee HW; Choi B; Wang HT; Hu Y; Mehta M; Desai D; Amin S; Zheng Y; Tang MS
Oncotarget; 2017 Mar; 8(11):18213-18226. PubMed ID: 28212554
[TBL] [Abstract][Full Text] [Related]
32. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
[TBL] [Abstract][Full Text] [Related]
33. Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer.
Guengerich FP; Johnson WW; Ueng YF; Yamazaki H; Shimada T
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):557-62. PubMed ID: 8781383
[TBL] [Abstract][Full Text] [Related]
34. Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan.
Wu HC; Wang Q; Yang HI; Ahsan H; Tsai WY; Wang LY; Chen SY; Chen CJ; Santella RM
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):846-53. PubMed ID: 19273485
[TBL] [Abstract][Full Text] [Related]
35. Risk Assessment of Hepatocellular Carcinoma with Aflatoxin B
Jubeen F; Zahra N; Nazli ZI; Saleemi MK; Aslam F; Naz I; Farhat LB; Saleh A; Alshawwa SZ; Iqbal M
Toxins (Basel); 2022 Aug; 14(8):. PubMed ID: 36006209
[TBL] [Abstract][Full Text] [Related]
36. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.
Yu MW; Chiang YC; Lien JP; Chen CJ
Carcinogenesis; 1997 Jun; 18(6):1189-94. PubMed ID: 9214602
[TBL] [Abstract][Full Text] [Related]
37. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.
Forrester LM; Neal GE; Judah DJ; Glancey MJ; Wolf CR
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8306-10. PubMed ID: 2122459
[TBL] [Abstract][Full Text] [Related]
38. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis.
Kew MC
Liver Int; 2003 Dec; 23(6):405-9. PubMed ID: 14986813
[TBL] [Abstract][Full Text] [Related]
39. Carcinogenic effects of aflatoxin B1 among wheat handlers.
Saad-Hussein A; Taha MM; Beshir S; Shahy EM; Shaheen W; Elhamshary M
Int J Occup Environ Health; 2014; 20(3):215-9. PubMed ID: 25000109
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.
Long XD; Zhao D; Wang C; Huang XY; Yao JG; Ma Y; Wei ZH; Liu M; Zeng LX; Mo XQ; Zhang JJ; Xue F; Zhai B; Xia Q
Epidemiology; 2013 Sep; 24(5):671-81. PubMed ID: 23788213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
